Clindamycin cellulitis dose

Inadequate dosing of clindamycin and TMP/SMX is independently associated with clinical failure in patients hospitalized with cellulitis. Further prospective studies evaluating weight-based dosing of clindamycin and TMP/SMX in the setting of cellulitis are warranted.

Adjunctive Clindamycin for Cellulitis: Clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis (C4C Trial)

o Clindamycin 10 mg/kg/dose IV q8h (max dose: 600mg). C) Non cellulitis. D) Common Pathogens. Diagnosis. Preseptal cellulitis.

Cellulitis (treatment of choice for non-purulent cellulitis). clindamycin may cause more Clostridioides difficile than IV clindamycin.

Cellulitis: Cellulitis is a bacterial infection of your skin and the Common medications include cephalexin, clindamycin and doxycycline.

Cellulitis (treatment of choice for non-purulent cellulitis). clindamycin dosing. 900 mg IV q8hr. Generally no dose adjustment for

Inadequate dosing of clindamycin and TMP/SMX is independently associated with clinical failure in patients hospitalized with cellulitis. Further prospective studies evaluating weight-based dosing of clindamycin and TMP/SMX in the setting of cellulitis are warranted.

Clindamycin For Cellulitis: Clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis (C4C Trial)

Adjunctive Clindamycin for Cellulitis: Clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis (C4C Trial)